Gambia Deaths: Govt panel holds first meet, says waiting for more papers from WHO

So far, the Haryana health authorities have halted all production at Sonipat-based Maiden pharmaceuticals on the grounds of deficiencies found during a joint inspection by central drug regulatory authority and Food and Drug Administration (FDA), Haryana.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news